- Home
- EVTV vs APM Comparison
EVTV vs APM Comparison
Compare EVTV & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- APM
- Stock Information
- Founded
- EVTV 2012
- APM 2010
- Country
- EVTV United States
- APM United Kingdom
- Employees
- EVTV N/A
- APM N/A
- Industry
- EVTV Auto Manufacturing
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- APM Health Care
- Exchange
- EVTV Nasdaq
- APM Nasdaq
- Market Cap
- EVTV 5.4M
- APM 5.6M
- IPO Year
- EVTV 2017
- APM 2018
- Fundamental
- Price
- EVTV $0.26
- APM $0.91
- Analyst Decision
- EVTV
- APM
- Analyst Count
- EVTV 0
- APM 0
- Target Price
- EVTV N/A
- APM N/A
- AVG Volume (30 Days)
- EVTV 106.4K
- APM 139.5K
- Earning Date
- EVTV 04-15-2025
- APM 05-06-2025
- Dividend Yield
- EVTV N/A
- APM N/A
- EPS Growth
- EVTV N/A
- APM N/A
- EPS
- EVTV N/A
- APM 0.00
- Revenue
- EVTV $1,870,060.00
- APM N/A
- Revenue This Year
- EVTV N/A
- APM $157,729.10
- Revenue Next Year
- EVTV N/A
- APM N/A
- P/E Ratio
- EVTV N/A
- APM $273.78
- Revenue Growth
- EVTV N/A
- APM N/A
- 52 Week Low
- EVTV $0.23
- APM $0.46
- 52 Week High
- EVTV $2.61
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- EVTV 44.80
- APM 49.72
- Support Level
- EVTV $0.23
- APM $0.79
- Resistance Level
- EVTV $0.27
- APM $1.34
- Average True Range (ATR)
- EVTV 0.02
- APM 0.11
- MACD
- EVTV 0.01
- APM 0.02
- Stochastic Oscillator
- EVTV 59.75
- APM 31.27
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.